Titan Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TTNP Nasdaq 2830 www.titanpharm.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - Jun 27th, 2025 2:05 pm
Titan announces filing of registration statement for proposed combination - Jun 4th, 2025 6:50 am
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. - Jun 3rd, 2025 6:45 am
Titan Pharmaceuticals: Q1 Earnings Snapshot - May 14th, 2025 4:49 pm
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - Apr 11th, 2025 2:15 pm
Titan Pharmaceuticals: Q4 Earnings Snapshot - Mar 20th, 2025 4:00 pm
Titan Pharmaceuticals: Q3 Earnings Snapshot - Jan 3rd, 2025 2:16 pm
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - Nov 27th, 2024 2:05 pm
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - Aug 19th, 2024 2:11 pm
Titan Pharmaceuticals: Q2 Earnings Snapshot - Aug 15th, 2024 7:40 am